Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nkarta Inc (NKTX)

Nkarta Inc (NKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Nkarta Stock Is Soaring Today Motley Fool - Wed Aug 14, 11:37AM CDT

One analyst is now more bullish about this clinical-stage biotech stock.

RJF : 123.62 (-0.39%)
NKTX : 5.25 (-2.42%)
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 FinancialNewsMedia - Tue Jan 9, 9:25AM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

ONCY : 0.9292 (-2.19%)
ONC.TO : 1.26 (-2.33%)
AMGN : 338.41 (+0.73%)
AMAM : 28.00 (+0.07%)
ELEV : 0.5810 (-3.13%)
NKTX : 5.25 (-2.42%)
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis PR Newswire - Tue Oct 17, 2023

/PRNewswire/ -- Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced a partnership with Nkarta, Inc. (Nasdaq:...

NKTX : 5.25 (-2.42%)
Why Shares of Nkarta Are Slumping Tuesday Motley Fool - Tue Jun 27, 2023

The pharmaceutical stock dropped after announcing so-so clinical trial results.

CRSP : 47.92 (-3.17%)
NKTX : 5.25 (-2.42%)
Nkarta Announces Key Senior Leadership Team Appointments Globe Newswire - Mon Jul 25, 2022

Ralph Brandenberger, PhD, promoted to Chief Technical OfficerYvonne Li, MBA, promoted to Chief Administrative OfficerEvolution of Nkarta leadership team to...

NKTX : 5.25 (-2.42%)
Nkarta to Participate at Upcoming Investor Conference Globe Newswire - Tue May 31, 2022

SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...

NKTX : 5.25 (-2.42%)
Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development Globe Newswire - Mon May 16, 2022

SOUTH SAN FRANCISCO, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing...

NKTX : 5.25 (-2.42%)
Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights Globe Newswire - Thu May 12, 2022

Positive preliminary data reported from NKX101 Phase 1 study in patients with relapsed / refractory AML; 3 of 5 patients treated with a 3-dose regimen of...

NKTX : 5.25 (-2.42%)
2 Red-Hot Stocks That Soared More Than 60% in April Motley Fool - Wed May 11, 2022

Could these be the next big meme stocks?

NKTX : 5.25 (-2.42%)
RDBX : 1.6500 (-52.86%)
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List? Motley Fool - Mon May 2, 2022

CEO Vas Narasimhan is seeking acquisitions under $2 billion.

NVS : 116.35 (+0.32%)
NKTX : 5.25 (-2.42%)
DICE : 47.55 (+0.06%)
IMCR : 33.48 (-2.13%)

Barchart Exclusives

1 'Strong Buy' Energy Stock That's a Free Cash Flow Gusher Barchart - 22 minutes ago
Seadrill Limited, a leading offshore drilling company, is poised to capitalize on the industry's resurgence, with a strong free cash flow outlook and strategic market advantages that could drive significant upside. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot